Correction: External validation of a machine learning model to predict hemodynamic instability in intensive care unit

• by Chiang Dung‑Hung, Tian Cong, Jiang Zeyu, Ou‑Yang Yu‑Shan, Lin Yung‑Yang

• September 29, 2026

The drugs and devices have been on the market for years. But FDA-ordered studies still aren’t done.

“Doctors rely on this evidence, patients rely on this evidence, and if that evidence is not there, it’s going to lead to a lot of uncertainty."

• by David Hilzenrath

• September 22, 2026

• 14 min

Interpreting viral severe acute respiratory infection in critically ill immunocompromised patients: phenotype, co-infections, and severity

• by Djamel Mokart, Frédéric Gonzalez, Laurent Chow-Chine, Magali Bisbal

• September 28, 2026

Correction to: HLA Class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

• by Jie Mei, Guanyu Jiang, Yundi Chen, Yongrui Xu, Yuan Wan, Ruo Chen, Feng Liu, Wenjun Mao, Mingfeng Zheng, Junying Xu

• September 17, 2026